Cargando…
Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine
BACKGROUND: Se-methylselenocysteine (MSC) is a naturally occurring organoselenium compound that inhibits mammary tumorigenesis in laboratory animals and in cell culture models. Previously we have documented that MSC inhibits DNA synthesis, total protein kinase C and cyclin-dependent kinase 2 kinase...
Autores principales: | Unni, Emmanual, Kittrell, Frances S, Singh, Uma, Sinha, Raghu |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC549175/ https://www.ncbi.nlm.nih.gov/pubmed/15318939 http://dx.doi.org/10.1186/bcr914 |
Ejemplares similares
-
Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitro
por: Unni, Emmanual, et al.
Publicado: (2005) -
L‐Se‐methylselenocysteine sensitizes lung carcinoma to chemotherapy
por: Ma, Jia, et al.
Publicado: (2021) -
Production of Se-methylselenocysteine in transgenic plants expressing selenocysteine methyltransferase
por: Ellis, Danielle R, et al.
Publicado: (2004) -
Simultaneous Dual Selective Targeted Delivery of Two Covalent Gemcitabine Immunochemotherapeutics and Complementary Anti-Neoplastic Potency of [Se]-Methylselenocysteine
por: Coyne, C. P., et al.
Publicado: (2015) -
Se-methylselenocysteine offers selective protection against toxicity and potentiates the antitumour activity of anticancer drugs in preclinical animal models
por: Cao, S, et al.
Publicado: (2014)